ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

CMRX Chimerix Inc

0,978
0,0278 (2,93%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Chimerix Inc CMRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,0278 2,93% 0,978 06:00:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,98 0,9374 0,98 0,9529 0,9502
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202413:00GLOBEChimerix Reports First Quarter 2024 Financial Results and..
24/4/202413:00GLOBEChimerix to Report First Quarter 2024 Financial Results and..
16/4/202422:05GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
21/3/202412:00GLOBEChimerix Appoints Marc D. Kozin to Board of Directors
29/2/202415:20EDGAR2Form S-3 - Registration statement under Securities Act of..
29/2/202414:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202413:58EDGAR2Form 8-K - Current report
29/2/202413:00GLOBEChimerix Reports Fourth Quarter and Year End 2023 Financial..
27/2/202413:00GLOBEChimerix to Present at TD Cowen 44th Annual Health Care..
22/2/202413:00GLOBEChimerix to Report Fourth Quarter and Year End 2023..
17/2/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202419:28EDGAR2Form 144 - Report of proposed sale of securities
14/2/202419:21EDGAR2Form 144 - Report of proposed sale of securities
14/2/202419:13EDGAR2Form 144 - Report of proposed sale of securities
12/2/202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/2/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202417:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/12/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:51EDGAR2Form 8-K - Current report
29/12/202313:00GLOBEChimerix Appoints Lisa Decker to Board of Directors
04/12/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202323:21EDGAR2Form 8-K - Current report
04/12/202313:00GLOBEChimerix Promotes Michelle LaSpaluto to Chief Financial..
24/11/202313:00GLOBEChimerix Reports Inducement Grant Under Nasdaq Listing Rule..
20/11/202321:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202300:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:15EDGAR2Form 8-K - Current report
16/11/202313:00GLOBEChimerix Strengthens Executive Leadership Team with..
13/11/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202313:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202313:02EDGAR2Form 8-K - Current report
02/11/202312:00GLOBEChimerix Reports Third Quarter 2023 Financial Results and..
26/10/202313:00GLOBEChimerix to Report Third Quarter 2023 Financial Results and..
29/9/202322:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/9/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202319:22EDGAR2Form 144 - Report of proposed sale of securities
26/9/202321:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202313:00GLOBEChimerix to Participate in Upcoming Investor Conferences
16/8/202316:05GLOBEChimerix Announces Data Highlighting Clinical Efficacy and..
03/8/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:11EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

Delayed Upgrade Clock